Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens
about
Promise of personalized omics to precision medicineTechnological considerations for genome-guided diagnosis and management of cancerAppraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastNovel diet-related mouse model of colon cancer parallels human colon cancerDetecting ultralow-frequency mutations by Duplex Sequencing.Multiple components of PKA and TGF-β pathways are mutated in pseudomyxoma peritoneiSystems biology: personalized medicine for the future?DNA Methylation in Breast Tumor from High-risk Women in the Breast Cancer Family Registry.The role of replicates for error mitigation in next-generation sequencing.Micro RNA detection in long-term fixed tissue of cortical glutamatergic pyramidal neurons after targeted laser-capture neuroanatomical microdissectionEvaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP-CGH analysis.Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.Personal genomes, quantitative dynamic omics and personalized medicineNext-generation sequencing is highly sensitive for the detection of beta-catenin mutations in desmoid-type fibromatoses.The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing.Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST).Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue SamplesRobust gene expression and mutation analyses of RNA-sequencing of formalin-fixed diagnostic tumor samples.Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNACopy number analysis by low coverage whole genome sequencing using ultra low-input DNA from formalin-fixed paraffin embedded tumor tissue.Comparing mutation calls in fixed tumour samples between the affymetrix OncoScan® array and PCR based next-generation sequencing.A review of room temperature storage of biospecimen tissue and nucleic acids for anatomic pathology laboratories and biorepositories.Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates.Next-generation sequencing in the clinic: promises and challenges.Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach.Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.Clonotyping for precision oncology.Clinical application of a cancer genomic profiling assay to guide precision medicine decisions.Studies of Polymorphism of Amyloid-β42 Peptide from Different Suppliers.AmpliVar: mutation detection in high-throughput sequence from amplicon-based libraries.Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.Next-generation sequencing of formalin-fixed, paraffin-embedded tumor biopsies: navigating the perils of old and new technology to advance cancer diagnosis.Personalized medicine-a modern approach for the diagnosis and management of hypertension.Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid.How to analyse the spatiotemporal tumour samples needed to investigate cancer evolution: A case study using paired primary and recurrent glioblastoma.Combination approach for detecting different types of alterations in circulating tumor DNA in leiomyosarcoma.Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations.Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
P2860
Q26852592-1A244FC4-BBBD-4AC5-8EE4-E250BD9C593DQ28066706-0C286189-BD44-42C2-8E0B-6266F89A7EA9Q28083103-947AC2BE-7CE4-40B2-B874-9129182B931EQ28243913-193059E8-DDDA-472D-BA1E-79C8F9313990Q30413211-A95B558C-AF3C-4023-88CD-EAD95028B7EEQ33584714-98CA4598-89E4-464B-9CE3-9562F5773390Q33824947-C162513C-21EB-44BC-BB8C-233146CF462DQ33893710-F2545AC1-21CA-4C57-A19F-B5CB5D166A10Q33921022-43F3DB5D-54DC-4F1D-A6D8-02084E849A66Q34115723-F4EDA8B9-8A07-46E6-90DF-1019C05B7ECFQ34560270-5F30B320-DB47-4D5D-826D-1D433FEB708DQ34659939-67500EAB-5C5A-4A0A-8931-28F523CD92B8Q35178113-6D3632A0-37EA-47FA-8C3C-B5F0A13D3209Q35195408-4081E2C0-BE1D-427D-8E56-192C00F1D92BQ35594642-57C9982D-84A3-4CF7-A361-C99031BA54F2Q35669976-AFABA276-5986-4FD0-A69C-8F6F8559E546Q35722718-47F99247-FF4E-42C4-A5EB-33BB62B513D3Q35831238-37ED8E2E-A571-4CA0-BE09-9295E5407FA2Q35862252-6CE3E3CD-AE9E-4A5D-9FBB-D411F9C47C28Q35881001-E581EC40-99A7-4698-8D3A-434128C9DA42Q36087015-D733DAF1-5785-4EC2-8AA5-4C54D140F76DQ36193492-1EE32BE3-B57A-45CF-B7CD-4A66AFEB16A6Q36313666-2929BCEA-17AB-4997-A5C1-99D534366204Q37685485-7184B1AB-511F-44B2-869A-2242D2D03AE6Q37731513-A41D413B-FB1F-4E67-96ED-BBB394771566Q38061737-42A6D7D3-84A8-4356-8C7F-04A2F4D051D9Q38373884-48265071-6202-426A-A8D6-4AB24EBCC6C2Q38384791-3C5C98CE-4B0A-4269-9FE5-02D41A506ED7Q38614405-43110918-1695-499F-A189-42D9E205E0FBQ40048521-EE018C4A-ED55-487D-B349-5B4FCA0006D7Q40507315-CC3D4D6A-4FC5-4C78-80F9-8DB9FCFF065FQ41460750-650B3343-770E-41A1-9D94-B88C8FC7B89AQ42315521-015BE496-6E3B-4A54-BC16-B8270B51F91EQ46412663-21EDB1CE-DAD8-445D-A627-71FC6814DC4AQ47095825-81398C42-74F9-4F82-B9C7-68E983A21EE8Q47887287-DDC53DF9-311B-4E03-AFAD-589F8443081EQ48197743-CA638F74-A003-44DB-B72F-16D578AE2954Q49791875-071F8407-0CFA-4689-AA06-EBE32FC1AB4BQ50696973-70FF15CF-E29F-43A7-B7FE-EB7968A77B79Q55071303-0050FDFE-0E22-440D-9E50-3579A639E074
P2860
Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Identification of high-confide ...... -fixed breast cancer specimens
@ast
Identification of high-confide ...... -fixed breast cancer specimens
@en
Identification of high-confide ...... -fixed breast cancer specimens
@nl
type
label
Identification of high-confide ...... -fixed breast cancer specimens
@ast
Identification of high-confide ...... -fixed breast cancer specimens
@en
Identification of high-confide ...... -fixed breast cancer specimens
@nl
prefLabel
Identification of high-confide ...... -fixed breast cancer specimens
@ast
Identification of high-confide ...... -fixed breast cancer specimens
@en
Identification of high-confide ...... -fixed breast cancer specimens
@nl
P2093
P2860
P3181
P356
P1476
Identification of high-confide ...... -fixed breast cancer specimens
@en
P2093
Barbara A Parker
Emile Voest
Erin N Smith
HyunChul Jung
John P Pierce
Karen Messer
Kelly A Frazer
Richard B Schwab
Shawn E Yost
P2860
P3181
P356
10.1093/NAR/GKS299
P407
P577
2012-08-01T00:00:00Z